A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%

Clinical trial NCT01437982 · COMPLETED

Trial details

NCT number: NCT01437982
Sponsor: Bausch & Lomb Incorporated
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Conjunctivitis, Seasonal Allergic Conjunctivitis, Giant Papillary Inflammation

Start date: 2010-08-05
Primary completion: 2015-10-19
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.